title: Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
authors.forename: Ryohei
authors.initials: R
authors.lastname: Matsumoto
authors.forename: Yurinosuke
authors.initials: Y
authors.lastname: Kitabayashi
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Nakatomi
authors.forename: Hideto
authors.initials: H
authors.lastname: Tsuchida
authors.forename: Kenji
authors.initials: K
authors.lastname: Fukui
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D003987:Dibenzothiazepines / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D016666:Fluvoxamine; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors